PharmacoEconomics

Acknowledgement
pp. 1065-1067(3)

Is There a Role for Pharmacoeconomics in Developing Countries?
pp. 1069-1074(6)
Authors: Babar, Zaheer-Ud-Din; Scahill, Shane

The Economics of a `Liberated' NHS
pp. 1075-1078(4)
Author: Devlin, Nancy J.

The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments
pp. 1079-1096(18)
Authors: Manca, Andrea; Sculpher, Mark J.; Goeree, Ron

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices
pp. 1097-1107(11)
Authors: Shi, Lizheng; Liu, Jinan; Koleva, Yordanka; Fonseca, Vivian; Kalsekar, Anupama; Pawaskar, Manjiri

A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States
pp. 1109-1121(13)
Author: Mavranezouli, Ifigeneia

Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance
pp. 1123-1128(6)
Authors: Kaier, Klaus; Frank, Uwe

The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect® in Symptomatic Knee Cartilage Lesions in Belgium
pp. 1129-1146(18)
Authors: Gerlier, Laetitia; Lamotte, Mark; Wille, Micheline; Kreuz, Peter C.; Vanlauwe, Johan; Dubois, Dominique; Meurgey, François M.